ARTICLE | Management Tracks
Biotech CEOs in China: a broadening talent pool
It’s no longer only MNCs. CEOs from domestic biotechs, academia and investment communities a growing source of China CEOs
April 3, 2021 2:56 AM UTC
Growth in China’s biotech sector has driven up demand for executives who can run companies with innovative therapies that can compete on a global stage. BioCentury’s analysis shows that while MNCs remain the primary breeding ground for CEOs, domestic biotechs are now contributing almost as much talent, and the academic and investment communities are growing in impact.
The talent crunch is global, with new biotechs being formed at a pace that’s causing concern over the ability to staff and manage them with experienced hands, but in China it takes on extra urgency given the limited supply in the still-young ecosystem...